Ventricular Assist Devices Companies

ID: MRFR/HC/8299-HCR

120 Pages

Kinjoll Dey

September 2025

Ventricular Assist Devices (VADs) have emerged as crucial technological advancements in the field of cardiovascular medicine, offering a lifeline to patients suffering from severe heart failure. These devices serve as mechanical pumps that support the weakened heart by assisting in blood circulation.

Summary Table of Contents Segmentation Infographic

Ventricular Assist Devices Key Companies

Latest Ventricular Assist Devices Companies Update:

Abbott Received FDA approval for the HeartMate 3 Heart Pump for pediatric patients (December 2020).

SynCardia Systems Secured FDA approval for a 50cc temporary total artificial heart system in March 2020.

HeartWare International Entered an agreement with Abbott to market their HVAD System in Japan (July 2023).

Medtronic Launched their HVAD pump with Full AXIOS system in Europe (October 2023).

BTT (Berlin Heart) Announced clinical trial results showing positive outcomes for their MagLev pump in destination therapy patients (November 2023).

List of Ventricular Assist Devices Key companies in the market